Original Article
Causal associations between 45 dietary intake habits and urolithiasis: insights from genetic studies
Translational Andrology and Urology
2024;
13
(7)
:1074-1084
.
(31 July 2024)
Effectiveness of soft coagulation in robot-assisted partial nephrectomy in preventing pseudoaneurysms and its influence on renal function based on propensity score-matched analysis
Translational Andrology and Urology
2024;
13
(7)
:1085-1092
.
(31 July 2024)
Racial, ethnic, and socioeconomic disparities in rates of stage IV prostate cancer after USPSTF category “D” recommendation against prostate-specific antigen screening: a retrospective cohort study
Translational Andrology and Urology
2024;
13
(7)
:1093-1103
.
(31 July 2024)
Machine learning developed an intratumor heterogeneity signature for predicting clinical outcome and immunotherapy benefit in bladder cancer
Translational Andrology and Urology
2024;
13
(7)
:1104-1117
.
(31 July 2024)
Efficacy of avelumab maintenance therapy for advanced urothelial carcinoma with histologic subtype and divergent differentiation: a multicenter retrospective study conducted by the Uro-Oncology Group in Kyushu
Translational Andrology and Urology
2024;
13
(7)
:1118-1126
.
(31 July 2024)
Comparative efficacy of different surgical techniques for pediatric urolithiasis—a systematic review and meta-analysis
Translational Andrology and Urology
2024;
13
(7)
:1127-1144
.
(31 July 2024)
METTL14 inhibits the proliferation, migration and invasion of prostate cancer cells by increasing m6A methylation of CDK4
Translational Andrology and Urology
2024;
13
(7)
:1145-1163
.
(31 July 2024)
Evaluation of transurethral GreenLight laser-selective vaporization for refractory overactive bladder in women
Translational Andrology and Urology
2024;
13
(7)
:1164-1172
.
(31 July 2024)
Simplifying vasectomy reversal without compromising outcomes: a single-surgeon series
Translational Andrology and Urology
2024;
13
(7)
:1173-1179
.
(31 July 2024)
A novel T1a/b classification for testicular cancer: not only seminoma
Translational Andrology and Urology
2024;
13
(7)
:1180-1187
.
(31 July 2024)
LncRNA ZFHX4-AS1 as a novel biomarker in adrenocortical carcinoma
Translational Andrology and Urology
2024;
13
(7)
:1188-1205
.
(31 July 2024)
Interaction of smoking and spicy habits modifies the risk of erectile dysfunction
Translational Andrology and Urology
2024;
13
(7)
:1206-1218
.
(31 July 2024)
Comparing the diagnostic value of 68Ga-prostate-specific membrane antigen PET/CT and multiparametric MRI in pelvic lymph node metastasis of locally advanced prostate cancer
Translational Andrology and Urology
2024;
13
(7)
:1219-1227
.
(31 July 2024)
Diagnostic value of oxidation-reduction potential for male infertility: a systematic review and meta-analysis
Translational Andrology and Urology
2024;
13
(7)
:1228-1238
.
(31 July 2024)
Silencing SPP1 in M2 macrophages inhibits the progression of castration-resistant prostate cancer via the MMP9/TGFβ1 axis
Translational Andrology and Urology
2024;
13
(7)
:1239-1255
.
(31 July 2024)
Risk factors for distant metastasis and prognosis of the penile cancer with distant metastasis
Translational Andrology and Urology
2024;
13
(7)
:1256-1267
.
(31 July 2024)
Surgical Technique
The surgical technique and protocol for dynamic sentinel node biopsy for penile cancer at a Southeast Asian regional hospital
Translational Andrology and Urology
2024;
13
(7)
:1268-1277
.
(31 July 2024)
Review Article
A review of tanshinone compounds in prostate cancer treatment
Translational Andrology and Urology
2024;
13
(7)
:1278-1287
.
(31 July 2024)
Risk factors for secondary bladder cancer following prostate cancer radiotherapy
Translational Andrology and Urology
2024;
13
(7)
:1288-1296
.
(31 July 2024)
Case Report
Treatment of obstructive sleep apnea relieves stuttering priapism in patient with sickle cell disease: a case report
Translational Andrology and Urology
2024;
13
(7)
:1297-1301
.
(31 July 2024)
The application of laparoscopic ultrasound-guided intervention in renal hybrid surgery: case report
Translational Andrology and Urology
2024;
13
(7)
:1302-1308
.
(31 July 2024)
Editorial Commentary
Strategies for optimizing pain management after ureteroscopy
Translational Andrology and Urology
2024;
13
(7)
:1309-1311
.
(31 July 2024)
Stereotactic ablative radiotherapy: a game-changer in primary renal cancer therapy
Translational Andrology and Urology
2024;
13
(7)
:1312-1314
.
(31 July 2024)
Combination of PARP and DNA methylation inhibitors as a potential personalized therapy for SETD2-mutated clear-cell renal cancers
Translational Andrology and Urology
2024;
13
(7)
:1315-1318
.
(31 July 2024)
Imposter among us: field cancerization in the bladder
Translational Andrology and Urology
2024;
13
(7)
:1319-1323
.
(31 July 2024)
Feasibility of androgen-deprivation and radiation therapy with docetaxel for localized high-risk prostate cancer
Translational Andrology and Urology
2024;
13
(7)
:1324-1326
.
(31 July 2024)
Avelumab first-line maintenance for advanced or metastatic urothelial carcinoma: analysis from JAVELIN Bladder 100 trial
Translational Andrology and Urology
2024;
13
(7)
:1327-1328
.
(31 July 2024)
Time to diversify: germline exome sequencing for men with testicular germ cell tumour
Translational Andrology and Urology
2024;
13
(7)
:1329-1332
.
(31 July 2024)
Validity and utility of switch-maintenance therapy with nivolumab in tyrosine kinase inhibitor-sensitive patients with metastatic renal cell carcinoma: learning from NIVOSWITCH
Translational Andrology and Urology
2024;
13
(7)
:1333-1335
.
(31 July 2024)
